{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:22:40Z","timestamp":1790788960233,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s40620-018-0559-2","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T09:43:19Z","timestamp":1542793399000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Control of metabolic predisposition to cardiovascular complications of chronic kidney disease by effervescent calcium magnesium citrate: a feasibility study"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3181-9065","authenticated-orcid":false,"given":"Henry","family":"Qui\u00f1ones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamim","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayar","family":"Sakhaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orson W.","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Y. C.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"issue":"10100","key":"559_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/s0140-6736(17)32154-2","volume":"390","author":"GBD","year":"2016","unstructured":"GBD (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016 (2017). Lancet 390(10100):1211\u20131259. https:\/\/doi.org\/10.1016\/s0140-6736(17)32154-2","journal-title":"Lancet"},{"issue":"2","key":"559_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1053\/j.ajkd.2013.03.009","volume":"62","author":"ME Grams","year":"2013","unstructured":"Grams ME, Chow EK, Segev DL, Coresh J (2013) Lifetime incidence of CKD stages 3\u20135 in the United States. Am J Kidney Dis 62(2):245\u2013252. https:\/\/doi.org\/10.1053\/j.ajkd.2013.03.009","journal-title":"Am J Kidney Dis"},{"key":"559_CR3","volume-title":"United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States","author":"USRD System","year":"2015","unstructured":"System USRD (2015) United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 2017"},{"issue":"Suppl 1","key":"559_CR4","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.2215\/CJN.04860709","volume":"4","author":"RJ Glassock","year":"2009","unstructured":"Glassock RJ, Pecoits-Filho R, Barberato SH (2009) Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4(Suppl 1):S79\u2013S91. https:\/\/doi.org\/10.2215\/cjn.04860709","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"559_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00467-009-1337-0","volume":"25","author":"KA Hruska","year":"2010","unstructured":"Hruska KA, Choi ET, Memon I, Davis TK, Mathew S (2010) Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Pediatr Nephrol 25(4):769\u2013778. https:\/\/doi.org\/10.1007\/s00467-009-1337-0","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"559_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40620-016-0309-2","volume":"29","author":"DG Moledina","year":"2016","unstructured":"Moledina DG, Perazella MA (2016) PPIs and kidney disease: from AIN to CKD. J Nephrol 29(5):611\u2013616. https:\/\/doi.org\/10.1007\/s40620-016-0309-2","journal-title":"J Nephrol"},{"issue":"1","key":"559_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40620-014-0071-2","volume":"28","author":"D Russo","year":"2015","unstructured":"Russo D, Bellasi A, Pota A, Russo L, Di Iorio B (2015) Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease. J Nephrol 28(1):73\u201380. https:\/\/doi.org\/10.1007\/s40620-014-0071-2","journal-title":"J Nephrol"},{"issue":"12","key":"559_CR8","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1016\/j.bpj.2010.10.030","volume":"99","author":"A Heiss","year":"2010","unstructured":"Heiss A, Pipich V, Jahnen-Dechent W, Schwahn D (2010) Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on Fetuin-A controlled calcification inhibition. Biophys J 99(12):3986\u20133995. https:\/\/doi.org\/10.1016\/j.bpj.2010.10.030","journal-title":"Biophys J"},{"issue":"11","key":"559_CR9","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1681\/ASN.2009090944","volume":"21","author":"T Hamano","year":"2010","unstructured":"Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y (2010) Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21(11):1998\u20132007. https:\/\/doi.org\/10.1681\/asn.2009090944","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"559_CR10","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1681\/ASN.2012030240","volume":"23","author":"A Pasch","year":"2012","unstructured":"Pasch A, Farese S, Graber S, Wald J, Richtering W, Floege J, Jahnen-Dechent W (2012) Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23(10):1744\u20131752. https:\/\/doi.org\/10.1681\/ASN.2012030240","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"559_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ki.2010.390","volume":"79","author":"AP Sage","year":"2011","unstructured":"Sage AP, Lu J, Tintut Y, Demer LL (2011) Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79(4):414\u2013422. https:\/\/doi.org\/10.1038\/ki.2010.390","journal-title":"Kidney Int"},{"issue":"7","key":"559_CR12","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1681\/ASN.2008101106","volume":"20","author":"E Shuto","year":"2009","unstructured":"Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, Nashiki K, Amo K, Yamamoto H, Higashi Y, Nakaya Y, Takeda E (2009) Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 20(7):1504\u20131512. https:\/\/doi.org\/10.1681\/asn.2008101106","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"559_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1681\/ASN.2013060635","volume":"25","author":"ER Smith","year":"2014","unstructured":"Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, Rajkumar C, Holt SG, Pasch A (2014) Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 25(2):339\u2013348. https:\/\/doi.org\/10.1681\/asn.2013060635","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"559_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1053\/j.ajkd.2013.03.042","volume":"62","author":"GA Block","year":"2013","unstructured":"Block GA, Ix JH, Ketteler M, Martin KJ, Thadhani RI, Tonelli M, Wolf M, Juppner H, Hruska K, Wheeler DC (2013) Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. Am J Kidney Dis 62(3):457\u2013473. https:\/\/doi.org\/10.1053\/j.ajkd.2013.03.042","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"559_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40620-016-0266-9","volume":"29","author":"J Floege","year":"2016","unstructured":"Floege J (2016) Phosphate binders in chronic kidney disease: a systematic review of recent data. J Nephrol 29(3):329\u2013340. https:\/\/doi.org\/10.1007\/s40620-016-0266-9","journal-title":"J Nephrol"},{"issue":"5","key":"559_CR16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/joneph\/23.5.556","volume":"23","author":"V Panichi","year":"2010","unstructured":"Panichi V, Bigazzi R, Paoletti S, Mantuano E, Beati S, Marchetti V, Bernabini G, Grazi G, Giust R, Rosati A, Migliori M, Pasquariello A, Panicucci E, Barsotti G, Bellasi A (2010) Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study. J Nephrol 23(5):556\u2013562","journal-title":"J Nephrol"},{"issue":"4","key":"559_CR17","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6(4):913\u2013921. https:\/\/doi.org\/10.2215\/cjn.06040710","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"559_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1681\/ASN.2014020205","volume":"26","author":"M Dobre","year":"2015","unstructured":"Dobre M, Rahman M, Hostetter TH (2015) Current status of bicarbonate in CKD. J Am Soc Nephrol 26(3):515\u2013523. https:\/\/doi.org\/10.1681\/asn.2014020205","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"559_CR19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/sdi.12411","volume":"28","author":"AJ Felsenfeld","year":"2015","unstructured":"Felsenfeld AJ, Levine BS, Rodriguez M (2015) Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease. Seminars in dialysis 28(6):564\u2013577. https:\/\/doi.org\/10.1111\/sdi.12411","journal-title":"Seminars in dialysis"},{"issue":"8489","key":"559_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S0140-6736(86)91329-2","volume":"1","author":"DJ Kok","year":"1986","unstructured":"Kok DJ, Papapoulos SE, Bijvoet OL (1986) Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1(8489):1056\u20131058","journal-title":"Lancet"},{"issue":"7","key":"559_CR21","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1681\/ASN.2014040332","volume":"26","author":"T Banerjee","year":"2015","unstructured":"Banerjee T, Crews DC, Wesson DE, Tilea AM, Saran R, Rios-Burrows N, Williams DE, Powe NR, Centers for Disease C, Prevention Chronic Kidney Disease Surveillance T (2015) High dietary acid load predicts ESRD among adults with CKD. J Am Soc Nephrol 26(7):1693\u20131700. https:\/\/doi.org\/10.1681\/ASN.2014040332","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"559_CR22","doi-asserted-by":"publisher","first-page":"e116273","DOI":"10.1371\/journal.pone.0116273","volume":"9","author":"Y Sakaguchi","year":"2014","unstructured":"Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Iseki K, Tsubakihara Y, Isaka Y, Committee of Renal Data Registry of the Japanese Society for Dialysis T (2014) Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study. PLoS One 9(12):e116273. https:\/\/doi.org\/10.1371\/journal.pone.0116273","journal-title":"PLoS One"},{"issue":"3","key":"559_CR23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.juro.2008.10.141","volume":"181","author":"CY Pak","year":"2009","unstructured":"Pak CY, Moe OW, Maalouf NM, Zerwekh JE, Poindexter JR, Adams-Huet B (2009) Comparison of semi-empirical and computer derived methods for estimating urinary saturation of brushite. J Urol 181(3):1423\u20131428. https:\/\/doi.org\/10.1016\/j.juro.2008.10.141","journal-title":"J Urol"},{"issue":"6","key":"559_CR24","doi-asserted-by":"publisher","first-page":"e0156891","DOI":"10.1371\/journal.pone.0156891","volume":"11","author":"N Sekercioglu","year":"2016","unstructured":"Sekercioglu N, Thabane L, Diaz Martinez JP, Nesrallah G, Longo CJ, Busse JW, Akhtar-Danesh N, Agarwal A, Al-Khalifah R, Iorio A, Guyatt GH (2016) Comparative effectiveness of Pposphate binders in patients with chronic kidney disease: a systematic review and network meta-analysis. PloS one 11(6):e0156891. https:\/\/doi.org\/10.1371\/journal.pone.0156891","journal-title":"PloS one"},{"issue":"15","key":"559_CR25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1056\/NEJM199104113241502","volume":"324","author":"KD Fine","year":"1991","unstructured":"Fine KD, Santa Ana CA, Fordtran JS (1991) Diagnosis of magnesium-induced diarrhea. N Engl J Med 324(15):1012\u20131017. https:\/\/doi.org\/10.1056\/nejm199104113241502","journal-title":"N Engl J Med"},{"issue":"2","key":"559_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.116.07664","volume":"68","author":"X Zhang","year":"2016","unstructured":"Zhang X, Li Y, Del Gobbo LC, Rosanoff A, Wang J, Zhang W, Song Y (2016) Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension 68(2):324\u2013333. https:\/\/doi.org\/10.1161\/hypertensionaha.116.07664","journal-title":"Hypertension"},{"issue":"9","key":"559_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.amjmed.2013.02.036","volume":"126","author":"S Laecke Van","year":"2013","unstructured":"Van Laecke S, Nagler EV, Verbeke F, Van Biesen W, Vanholder R (2013) Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease. Am J Med 126(9):825\u2013831. https:\/\/doi.org\/10.1016\/j.amjmed.2013.02.036","journal-title":"Am J Med"},{"issue":"9","key":"559_CR28","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2215\/CJN.13921217","volume":"13","author":"I Bressendorff","year":"2018","unstructured":"Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L (2018) The effect of increasing dialysate magnesium on serum calcification propensity in subjects with end stage kidney disease: a randomized, controlled clinical trial. Clin J Am Soc Nephrol 13(9):1373\u20131380. https:\/\/doi.org\/10.2215\/cjn.13921217","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"559_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s40620-014-0140-6","volume":"28","author":"J Floege","year":"2015","unstructured":"Floege J (2015) Magnesium in CKD: more than a calcification inhibitor? J Nephrol 28(3):269\u2013277. https:\/\/doi.org\/10.1007\/s40620-014-0140-6","journal-title":"J Nephrol"},{"issue":"5","key":"559_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2215\/CJN.08340812","volume":"8","author":"MK Abramowitz","year":"2013","unstructured":"Abramowitz MK, Melamed ML, Bauer C, Raff AC, Hostetter TH (2013) Effects of oral sodium bicarbonate in patients with CKD. Clin J Am Soc Nephrol 8(5):714\u2013720. https:\/\/doi.org\/10.2215\/cjn.08340812","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"559_CR31","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1681\/ASN.2008111205","volume":"20","author":"I Brito-Ashurst de","year":"2009","unstructured":"de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM (2009) Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20(9):2075\u20132084. https:\/\/doi.org\/10.1681\/asn.2008111205","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"559_CR32","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/ki.2014.83","volume":"86","author":"N Goraya","year":"2014","unstructured":"Goraya N, Simoni J, Jo CH, Wesson DE (2014) Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int 86(5):1031\u20131038. https:\/\/doi.org\/10.1038\/ki.2014.83","journal-title":"Kidney Int"},{"issue":"3","key":"559_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ki.2010.129","volume":"78","author":"A Mahajan","year":"2010","unstructured":"Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE (2010) Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int 78(3):303\u2013309. https:\/\/doi.org\/10.1038\/ki.2010.129","journal-title":"Kidney Int"},{"issue":"3","key":"559_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1053\/j.jrn.2006.12.012","volume":"17","author":"G Mircescu","year":"2007","unstructured":"Mircescu G, Garneata L, Stancu SH, Capusa C (2007) Effects of a supplemented hypoproteic diet in chronic kidney disease. J Renal Nutr 17(3):179\u2013188. https:\/\/doi.org\/10.1053\/j.jrn.2006.12.012","journal-title":"J Renal Nutr"},{"issue":"2","key":"559_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.ki.5002647","volume":"73","author":"S Phisitkul","year":"2008","unstructured":"Phisitkul S, Hacker C, Simoni J, Tran RM, Wesson DE (2008) Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors. Kidney Int 73(2):192\u2013199. https:\/\/doi.org\/10.1038\/sj.ki.5002647","journal-title":"Kidney Int"},{"issue":"4","key":"559_CR36","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","volume":"68","author":"GA Block","year":"2005","unstructured":"Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P (2005) Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68(4):1815\u20131824. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00600.x","journal-title":"Kidney Int"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-0559-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:05Z","timestamp":1777564565000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/1\/93\/8328136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0559-2","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"2 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The results presented in this paper have not been published previously in whole or part. Drs. Moe, Sakhaee and Pak are co-inventors on issued patent 9,539,283. Dr. Pasch is the co-inventor of the T50-test and co-founder of Calciscon, an entity which commercializes the T50-test. Dr. Pasch is also the current CEO of Calciscon and holds stock in the company. Drs. Quinones and Hamdi have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All protocols were approved by the Institutional Review Boards at UT Southwestern and DaVita.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}